AsiaIntervention
A randomised controlled trial comparing a 100% chitosan haemostatic dressing and a manual compression device following transradial coronary intervention
By Pandey CB, Garg N, Kapoor A and 7 others.
Abstract
Background
Haemostasis at radial access sites following transradial coronary intervention (TRCI) is usually achieved using manual compression devices (MCDs). Despite their widespread use, MCDs have limitations, including prolonged compression and haemostasis times as well as increased risk of radial artery occlusion (RAO), thus highlighting the need for alternative strategies to achieve faster and safer radial haemostasis.
Aims
We sought to compare the safety and efficacy of a 100% chitosan haemostatic dressing (CHD) with an MCD in achieving radial access site haemostasis following TRCI.
Methods
A total of 258 patients were randomly assigned to receive either a CHD (n=130; Axiostat) or an MCD (n=128; TR Band) for radial haemostasis following TRCI. Time to haemostasis, post-application pain, and access site complications - including rebleeding, haematoma, RAO, and allergic reactions - were assessed.